Skip to main content

Published

Nirmatrelvir plus ritonavir and tocilizumab for treating COVID-19 [NICE]
National Institute for Health and Care Excellence (NICE); 2026.
https://www.nice.org.uk/guidance/ta878
[Technology appraisal guidance TA878. Last updated: 26 February 2026. Removed the recommendation on sotrovimab. This is because GlaxoSmithKline has discontinued manufacturing, supply, distribution and marketing of sotrovimab in the UK.]
Freely available online

Age Groups
Adults
Conditions and Lifestyle Factors
Coronavirus Infections
Settings
Emergency Department
Hospital Ward
Intensive Care
Urgent Care in the Community
Staff Groups
Foundation Year Doctor
Medic
Nurse
Nurse Specialist
Pharmacist
Physician Associate